Physician profile
Robert S Kramer
NPI 1295888436
$7,520.82
in general payments reported to CMS, 2019-2025
14 companies · $2,918 in 2025
The $2,918 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,146 · 2020: $79.99 · 2021: $82.50 · 2024: $295 · 2025: $2,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,921 · Food and Beverage: $1,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,920.59 |
| Food and Beverage | $1,291.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $3,625.47 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $2,992.62 | 2019-2025 | Persona |
| Depuy Synthes Sales INC. | $251.95 | 2019-2024 | Monovisc |
| Spinesmith Holdings, LLC | $213.48 | 2019 | |
| Davol INC. | $163.84 | 2024 | Arista Ah Flexitip |
| Bioventus LLC | $43.64 | 2025 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $42.65 | 2024 | Vistaseal |
| Stryker Corporation | $41.52 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $40.79 | 2024-2025 | |
| Solventum Corporation | $30.15 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Medtronic, INC. | $21.67 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $20.79 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $18.52 | 2025 | Iovera, Zilretta |
| Innovation Technologies INC | $13.73 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.